Department of Neurosurgery, Rouen University Hospital, Rouen, France.
J Neurosurg. 2012 Dec;117(6):1013-21. doi: 10.3171/2012.9.JNS12167. Epub 2012 Oct 12.
The objective of this study was to evaluate the ophthalmological outcome, nonvisual morbidity, and surgical complications after tuberculum sellae meningioma (TSM) removal using a superior interhemispheric approach.
In the last decade, 20 consecutive patients with TSM underwent operations using the superior interhemispheric approach. Visual acuity, visual field, and ocular fundus examination were assessed both preoperatively and 6-months postoperatively. Nonvisual morbidity was determined at an early postoperative period and at 6 months based on assessment of the Karnofsky Performance Scale score, leakage of CSF, endocrinological status, and olfactory function, which was assessed using a visual analog scale (VAS). The potential brain injury related to the approach was assessed by MRI at 6 months. Magnetic resonance imaging was then performed yearly to detect a recurrence. The mean follow up was 56.3 ± 34 months.
The primary presenting symptom for diagnosis of TSM in 20 patients (female:male ratio of 6.6:1, mean age 59.1 ± 11.1 years) was visual disturbance in 12 patients (60%), headache in 4 (20%), cognitive alteration in 1 (5%), epilepsy in 2 (10%), and accidental in 1 (5%). In a total of 40 eyes, 17 eyes in 11 patients presented with preoperative deterioration of visual acuity. Postoperatively, the visual acuity improved in 13 eyes in 8 patients (72.8%), remained unchanged in 3 eyes in 2 patients (18.2%) and deteriorated in 1 patient (9%). The nonvisual morbidity included olfactory deterioration in 7 patients (35%), and panhypopituitarism in 1 patient (5%). No patients experienced a CSF leak. The impact of olfactory deterioration on the quality of life, as estimated by a VAS score (range 0-10), was a mean of 5.7 ± 2.2 (95% CI 4.1-7.3). On the follow-up MRI, no additional lesions or recurrences were observed on the medial aspect of the frontal lobe along the surgical corridor.
The superior interhemispheric approach appears to be effective in resolving the problem of visual deterioration due to a TSM, without inducing surgical injury on the brain surface along the surgical corridor. Olfactory deterioration remained the challenging predominant nonvisual morbidity using this approach.
本研究旨在评估经额上沟入路切除鞍结节脑膜瘤(TSM)后的眼科结局、非视觉性发病率和手术并发症。
在过去十年中,20 例连续的 TSM 患者采用额上沟入路手术。分别于术前和术后 6 个月进行视力、视野和眼底检查。根据卡诺夫斯基表现量表评分、CSF 漏、内分泌状态和嗅觉功能评估,在术后早期和 6 个月时确定非视觉性发病率,嗅觉功能采用视觉模拟评分(VAS)评估。术后 6 个月通过 MRI 评估与入路相关的潜在脑损伤。然后每年进行 MRI 以检测复发。平均随访时间为 56.3 ± 34 个月。
20 例患者(女:男比例为 6.6:1,平均年龄 59.1 ± 11.1 岁)的主要首发症状为 12 例(60%)的视觉障碍、4 例(20%)的头痛、1 例(5%)的认知改变、2 例(10%)的癫痫发作和 1 例(5%)的意外发现。在总共 40 只眼中,11 例患者的 17 只眼术前视力下降。术后,8 例患者的 13 只眼视力改善(72.8%),2 例患者的 3 只眼视力不变(18.2%),1 例患者(9%)视力恶化。非视觉性发病率包括 7 例(35%)嗅觉恶化和 1 例(5%)全垂体功能减退。无患者发生 CSF 漏。嗅觉恶化对生活质量的影响,通过 VAS 评分(范围 0-10)评估,平均为 5.7 ± 2.2(95%CI 4.1-7.3)。在随访 MRI 上,未在手术通道沿中线的额叶内侧观察到其他病变或复发。
经额上沟入路似乎可有效解决 TSM 引起的视力恶化问题,而不会在手术通道沿脑表面造成手术损伤。嗅觉恶化仍然是使用该入路的主要非视觉性发病率问题。